Skip to main content

Neurogene Inc 8-K, filed Nov 9, 2026

Neurogene Inc. (NGNE)

8-K 2026-11-09 For: 2026-11-09
View Original
Added on November 09, 2026

About this 8-K

Neurogene Inc filed this 8-K on November 9, 2026.

Neurogene reported $359.7 million in cash and investments as of September 30, 2026, funding operations into first quarter 2029. NGN-401 Embolden topline data are expected in 2H 2027, with PPQ runs expected to complete by year-end 2026. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits